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Abstract
Background: The use of indwelling medical devices is associated with a significant risk of infections by Staphylococcus
aureus (S. aureus) which possesses a variety of virulence factors including many toxins and the ability to invade
eukaryotic cells or to form biofilm on biotic and abiotic surfaces. The virulence factors above described are often
related to proteins exposed on the bacterial surface. Blocking S. aureus colonization may reduce the incidence of
invasive infectious diseases.
Previously reports evaluated the anti-infective properties of serratiopeptidase (Spep), an extracellular metalloprotease
produced by Serratia marcescens ATCC 21074 (E-15), in impairing virulence-related staphylococcal properties, such as
attachment to inert surfaces and adhesion/invasion on eukaryotic cells. However, to date its mechanism of action is
unknown.
Methods: Spep gene was PCR amplified and cloned into expression vector pET28b(+). The mutant EspepA was
constructed from plasmid pET28b-Spep applying the one-step overlap extension PCR strategy. There sulting plasmids
were costransformed in EcBL21(DE3) cells with the plasmid pRuW4inh1 harboring the Erwinia chrysanthemi secretion
system.
Bacterial pellets and supernatants were collected and analyzed by SDS-PAGE and zymography. The unambiguous
identification and a detailed structure characterization of both the wild type and the mutant Spep were obtained by
mass spectrometric analyses.
The resultant supernatants sterilized by filtration were separately used to condition biofilm formation of S. aureus.
Quantification was based on crystal violet method.
Results: In this work we constructed Spep mutant by substituting the glutamic acid in the catalytic site with a residue
of alanine. In this manner we were able to evaluate the anti-biofilm activity of Spep mutant in absence of proteolytic
activity. As expected, this mutant did not display protease activity but it retained its anti-biofilm properties, suggesting
that this action is independent by enzymatic activity.
Conclusions: New knowledge obtained from data reported in this paper calls attention to a novel mechanism of
action of Spep. This protein could be developed as a potential “antipathogenic agent” capable to impair the ability
of S. aureus to form biofilm on prostheses, catheters and medical devices, exploiting a mechanism different from the
proteolytic activity.
Keywords: Serratiopeptidase, Biofilm, S. aureus, Antivirulence
* Correspondence: marco.artini@uniroma1.it
1Department of Public Health and Infectious Diseases, Sapienza University,
p.le Aldo Moro 5, 00185 Rome, Italy
Full list of author information is available at the end of the article
© 2015 Selan et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Selan et al. BMC Microbiology  (2015) 15:207 
DOI 10.1186/s12866-015-0548-8
Background
S. aureus is a flexible microbial pathogen frequently iso-
lated from community-acquired and nosocomial infec-
tions [1]. The rapid emergence of hospital associated,
antibiotic resistant S. aureus is now recognized as major
epidemiological problem worldwide [2]. Moreover, the
ability of S. aureus to adhere on both eukaryotic cells and
abiotic surfaces via cell wall proteins and to form biofilm
are important virulence factors in chronic infections asso-
ciated with implanted biomaterials, which are particularly
difficult to eradicate [3–5]. Hence, not surprisingly, the
interest in the development of alternative anti-infective
approaches for the prevention and treatment of staphylo-
coccal infections has increased in recent years [6–9]. An
innovative approach should target S. aureus major viru-
lence factors without affecting bacterial viability.
With the aim of targeting some surface-related virulence
features of staphylococci our first choice was to use a
protease. In literature is reported the in vivo effect of the
protease Esp secreted by S. epidermidis acting as an anti-
biofilm and anti-colonisation agent against S. aureus cells
living in the same ecological niche [10]. Previously we fo-
cused our attention on serratiopeptidase (Spep), an extra-
cellular metalloprotease produced by the Gram-negative
opportunistic pathogen Serratia marcescens [11].
Spep contains a zinc binding consensus HEXXHX
XGXXH, where the three histidine are zinc ligands, and
the glutamic acid is the catalytic base [12]. Spep is com-
monly used as an anti-inflammatory agent and it has been
shown to modulate adhesin expression in some bacterial
species and to enhance antibiotic efficacy towards biofilm-
forming bacteria [13–16].
Previously the ability of Spep to impair some virulence
properties of different S. aureus strains, like attachment
to inert surfaces and adhesion/invasion of eukaryotic
cells was evaluated. The treatment with Spep is able to
hinder the attachment to abiotic surface and the inva-
sion of human cells by S. aureus strains without affect
bacterial viability. Spep was found to affect different
surface proteins in S. aureus biofilm [9, 13, 16].
However, previous work does not explain the mechan-
ism used by Spep to impair the S. aureus biofilm.
With the aim to understand the mechanism of Spep
action to impair the adhesive properties of S. aureus, we
expressed a recombinant form with a residue of alanine
in substitution of glutamic acid, to delete its proteolytic
activity. Surprisingly this mutant form retains the anti-
adhesive behavior suggesting a novel mechanism of ac-
tion or regulatory function to date unknown.
Methods
Construction of the expression vectors pET28b-Spep and
pET28b-Spep-EmutA
Genomic DNA preparation from S. marcescens ATCC
21074 E-15 (purchased by ATCC collection) was carried
out as reported by Alonso and co-workers [17].
The pET28b-Spep gene expression vector was con-
structed by cloning DNA fragment corresponding to the
coding gene of Spep of S. marcescens E-15 (Table 1) into
pET28b (+) vector. Spep gene was PCR amplified by
using the primers SPEP fw EcoRI/NcoI and SPEP rv
EcoRI reported in Table 1.
The amplified fragments were digested with NcoI and
EcoRI and cloned in pET28b (+) corresponding sites.
The nucleotide sequence was checked to rule out the oc-
currence any mutation during synthesis.
The mutant EspepA was constructed from plasmid
pET28b-Spep applying the one-step overlap extension
PCR (OOE-PCR) strategy [18, 19]. Either the fw/rev
EmutA primers, reported in Table 1, were designed to
introduce a single-point mutation, thereby substituting
the glutamic acid residue (Glu) with an alanine residue
(Ala). The resulting construct was indicated as pET28b-
Spep-EmutA.
The nucleotide sequence was checked to rule out the
occurrence any mutation during synthesis.
Expression of recombinant Spep and Spep EmutA
The resulting constructs were separately costransformed
in EcBL21(DE3) cells with the plasmid pRuW4inh1
Table 1 Oligonucleotides and plasmids used in this work
Plasmid Description References
pET28b-Spep pET28b (+) containing the Spep gene of S. marcescens E-15 This work
pET28b-Spep-EmutA pET28b (+) containing the Spep-EmutA gene of S. marcescens E-15 This work
pRuW4inh1 Secretion system of Erwinia chrysanthemi [20]
Oligonucleotides
Spep fw EcoRI/NcoI 5’-GGTAATGAGTGGAATTCAACCCATGGAATCTAC-3’
Spep rv EcoRI 5’-CATCACCGAATTCGTCACCATCATGC-3’
Spep_EmutA fw 5’-CGTTTACCCATGCGATTGGCCATGC-3’
Spep_EmutA rv 5’-GCATGGCCAATCGCATGGGTAAACG-3’
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harboring the Erwinia chrysanthemi secretion system
(kindly provided by prof. Wandersman) [20].
The recombinant Spep and Spep-EmutA genes were
separately expressed in EcBL21(DE3) cells, as follows:
fresh cultures were inoculated in LB medium containing
50 μg/mL of kanamycin and 34 μg/mL chloramphenicol.
The recombinant cells were grown over night at 37 °C.
Bacterial cells were subsequently diluted 1/100 and
grown until the OD600 reached 0.5. At this time point
5 mM IPTG was added to each culture and bacterial
pellets and supernatants were collected after 4 h by cen-
trifugation at 16627 g.
SDS-PAGE and Zymography
Supernatants were analyzed by SDS-PAGE and zymogra-
phy. A commercial sample of Spep (Takeda, Osaka, Japan)
was used as control (5 μg).
SDS-PAGE was carried out by standard methods with
SDS-polyacrylamide separating gel (10 % acrylamide
pH 8.8) and constant voltage (180 V) at room temperature.
Following electrophoresis, proteins were stained with
Coomassie brilliant blue (BIORAD).
Renaturing SDS-PAGE was performed as previously
reported by Artini and co-workers with some modifica-
tions [15]. SDS polyacrylamide separating gel (10 %
acrylamide pH 8.8) containing 0.5 % casein (wt/v) pro-
vided by Sigma was used to detect the lytic activity.
After electrophoresis gels were soaked in distilled water
at room temperature and then were transferred into the
renaturing buffer (50 mM TrisHCl pH 8 containing 1 %
Triton ×100) and shaken at 70 rpm for 2 h at 37 °C to
allow renaturation.
The renatured proteins appeared as clear translucent
bands on blue opaque background after Coomassie bril-
liant blue staining.
In situ digestion and Mass Spectrometry analysis
The Coomassie blue stained protein bands correspond-
ing to the wild type and mutant Spep were excised from
the gel and in situ digested with trypsin. Protein bands
were washed with acetonitrile (ACN) and then with
0.1 M ammonium bicarbonate. Protein samples were re-
duced by incubation with 10 mM DTT for 45 min at
56 °C. Cysteines were alkylated by treatment with 5 mM
iodoacetamide for 15 min at room temperature in the
dark. Gel particles were then washed with ammonium
bicarbonate and ACN. Tryptic digestion was carried out
using 12.5 ng/μl of enzyme in 50 mM ammonium bicar-
bonate pH 8.5 at 4 °C for 4 h.
The buffer solution was then removed and a new ali-
quot of enzyme/buffer solution was added for 18 h at
37 °C. A minimum reaction volume, enough for the
complete rehydratation of the gel was used. Peptides
were then extracted, washing the gel particles with
20 mM ammonium bicarbonate and 0.1 % TFA in 50 %
ACN at room temperature and then lyophilized.
The resulting peptide mixtures were analyzed by LC/
MS-MS (3520 Chip Q-Tof, Agilent) and the proteins
were identified in the NCBInr database using an in
house version of the MASCOT software.
Microtiter plate biofilm assay
Quantification of in vitro biofilm production was based
on the method described by Christensen with slight
modifications [15]. Briefly, the wells of a sterile 48-well
flat bottomed polystyrene plate were filled with an op-
portune volume of BHI and 5 % of cell free supernatants
derived form bacterial cultures harboring pET28b-Spep
and pET28b-Spep-EmutA, 10-fold concentrated with
10 kDa MWCO and sterilized by filtration. A suitable di-
lution of S. aureus 6538P culture in exponential growth
phase (about 0.1 OD 600 nm) was added into each well.
As control, biofilm formation was also performed using
Spep purchased by Takeda at a final concentration of
200 U/mL (80 μg/mL).
The sterile 48-well flat-bottomed polystyrene plate was
incubated for 24 h at 37 °C. Then, the supernatant cul-
tures were removed and adhered cells were washed with
double-distilled water and stained with 0.1 % crystal violet.
After adhered cells were rinsed twice with double-distilled
water, and thoroughly dried. The dye bound to adherent
cells was solubilized with 20 % (v/v) acetone and 80 % (v/
v) ethanol. The OD of each well was measured at 590 nm.
Each data point is composed of four independent samples.
Results and discussion
Analysis of expression and enzymatic activity of
recombinant Spep and Spep EmutA
The effect of SPEP treatment on virulence properties of
different S. aureus strains, such as attachment to inert
surfaces and adhesion/invasion of eukaryotic cells, was
already investigated. Although SPEP did not affect bac-
terial viability, it is able to impair attachment to abiotic
surface and invasiveness by S. aureus to human cells and
affects both biofilm formation and biofilm dispersion.
Nevertheless, previous work left unresolved by what
mechanism Spep interferes with S. aureus biofilm. For this
reason we decided to express a recombinant form of Spep.
Our recombinant form of Spep has a residue of ala-
nine in substitution of glutamic acid in zinc binding con-
sensus HEXXHXXGXXH. In this manner we were able
to evaluate the anti-biofilm activity of the Spep mutant
in absence of the proteolytic activity.
Recombinant forms of Spep and Spep-EmutA genes
were separately expressed in EcBL21(DE3) cells. Super-
natants of recombinant bacterial cells were analyzed by
SDS-PAGE and zymography (Fig. 1a-b). Results obtained
demonstrated that soluble recombinant proteins were
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efficiently produced by EcBL21(DE3) cells (Fig. 1a). Thus
the presence of inclusion bodies in the cytoplasm was
not evidenced (data not shown). Furthermore, recom-
binant proteins were correctly secreted in extracellular
medium despite a small amount of them was present in
the intracellular samples (data not shown).
The proteolytic activity of recombinant wild type Spep
was confirmed by zymogram analysis using 0.5 % of casein
as substrate (Fig. 1b). As clearly shown a translucent band
is present in the supernatant deriving from the culture
harboring pET28b-Spep (SN-Spep) while no protein band
was detected in the lane corresponding to the supernatant
deriving from the culture harboring pET28b-Spep-EmutA
(SN-SpepEmutA).
Identification and characterization of primary protein
structure of recombinant spep and spep-emutA
The unambiguous identification and a detailed structure
characterization of both the wild type and the mutant
Spep were obtained by mass spectrometric analyses. The
Coomassie blue stained protein bands corresponding to
the wild type and mutant Spep (Fig. 1a, lanes 1 and 2 re-
spectively) were excised from the gel and in situ digested
with trypsin as reported in Materials and Methods sec-
tion. The resulting peptide mixtures were analyzed by
LC/MS-MS (3520 Chip Q-Tof, Agilent) and the proteins
were identified in the NCBInr database using an in
house version of the MASCOT software. The presence
of Spep was confirmed in both bands showing a 62 %
Fig. 1 SDS-PAGE and zymogram analyses of supernatants of bacterial cultures harboring pET28b-Spep (lane 1) and pET28b-Spep-EmutA (lane 2),
respectively. Panel a SDS-PAGE and Panel b zymogram assays. Mk: precision Plus prestained marker, Biorad (range 250–10 kDa); C: 5 μg of SPEP
(2540 U mg−1, Osaka Japan). Panel c Mascot Search Results of the peptide mixtures derived from digestion with trypsin of the 1 and 2 bands
performed with LC/MS-MS (3520 Chip Q-Tof, Agilent)
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sequence coverage with 1182 MASCOT score for band 1
and 63 % sequence coverage with 1513 MASCOT score
for band 2, respectively. Results are summarized in Fig. 1c.
A detailed description of the mutant Spep including
the identification of the mutation site was obtained by
MALDI mass spectrometric analysis of the tryptic pep-
tide mixture generated by band 2. The accurate mass
values recorded in the spectra were mapped onto the an-
ticipated sequence of the Spep protein on the basis of
their mass value and the trypsin specificity. The mass
mapping strategy confirmed the identification and
allowed us to verify most of the Spep primary structure.
Moreover, the mass signal at m/z 3081.7 could only be
assigned to the peptide 172–200 where a Glu residue at
position 177 was substituted by Ala, thus confirming the
occurrence of the expected mutant.
Analysis of anti-biofilm activity of recombinant spep and
spep emutA
Cell free supernatants derived form bacterial cultures har-
boring pET28b-Spep and pET28b-Spep-EmutA, 10-fold
concentrated were separately used to condition biofilm
formation of S. aureus 6538P. As control, biofilm forma-
tion was also performed using Spep purchased by Takeda
(Osaka, Japan). Furthermore, biofilm formation was also
performed in the presence of supernatant derived by E.
coli BL21DE3, harboring both the vector pET28b and the
plasmid pRuW4inh1. This control excludes the possibility
that an E. coli component, secreted by the Erwinia chry-
santhemi secretion system, could effect S. aureus biofilm
formation. As already reported at a concentration of 200
U/mL (80 μg/mL) a quite complete disaggregation of bio-
film was evidenced (less than 5 % of residual biofilm) [16].
Results obtained showed that supernatants containing
wild type Spep and the inactivated mutant form of it were
both effective to impair S. aureus bioflm formation (Fig. 2).
Differently from other proteases like Esp [10], Spep
inactivated mutant was still able to disaggregate biofilm.
Conversely, Iwase and coworkers have identified that Esp
mechanism of action in the biofilm reduction is dependent
from its proteolytic activity [10]. Instead, by this data, we
can confirm that Spep is able to induce the reduction of
biofilm phenotype probably due to a regulating mechan-
ism, not yet identified, independent from its proteolytic
activity.
Conclusions
Thinking about a new approach against the biofilm of S.
aureus, a revolutionary strategy should target S. aureus
major virulence factors without affecting bacterial viabil-
ity. In this regard our results about the mechanism of
action of Spep against S. aureus biofilm are really inter-
esting. In literature is already reported the effect of the
protease Esp secreted by S. epidermidis acting as an
anti-biofilm and anti-colonisation agent against S. aureus
cells living in the same ecological niche but, conversely
to Esp, Spep does not get lose its activity when the cata-
lytic site was disrupted [21]. New knowledge obtained
from data reported in this paper, calls attention to a
novel mechanism of action of Spep different from its
proteolytic activity. In literature there are many cases of
proteins known to have a specific biological role that
however show alternative activities initially hidden [22].
Recently, several laboratories identifying proteins involved
in the complex processes of replication, transcription and
tumor suppression found that the ‘new’ proteins they dis-
covered had another, previously identified, function [22].
A single protein with multiple functions might seem sur-
prising, but there are actually many cases of proteins that
‘moonlight’, or have more than one role in an organism.
In this context, further efforts will be directed to the
identification of the mechanism responsible for the bio-
film regulation and to the identification of the molecular
partners in S. aureus interacting with Spep.
Fig. 2 Biofilm formation of S. aureus 6538P in the presence of supernatant deriving from E. coli BL21DE3 harboring pET28b-Spep and pET28b-Spep-
EmutA, respectively. Biofilm was reported as absorbance at 590 nm after crystal violet coloration. Results are representative of four
independent experiments
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